Double-Blind Randomized Clinical Trial to Examine the Pharmacokinetic and Clinical Impacts of Fixed Dose versus Weight-based Enoxaparin Prophylaxis: A Methodologic Description of the FIxed or Variable Enoxaparin (FIVE) Trial
Open Access
- 1 April 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 7 (4) , e2185
Abstract
Venous thromboembolism is an important patient safety in plastic surgery, and multiple clinical trials in the past 10 years have provided increased understanding of the risks and benefits of venous thromboembolism prevention strategies. This paper provides an exhaustive discussion of the rationale behind and methodology for an in progress randomized double-blind clinical trial in plastic surgery inpatients, in which the 2 study arms are enoxaparin 40 mg twice daily and enoxaparin 0.5 mg/kg twice daily. The trial’s primary aims are to: (1) demonstrate whether enoxaparin 0.5 mg/kg twice daily is superior to enoxaparin 40 mg twice daily for the pharmacokinetic endpoint of overanticoagulation (anti-Factor Xa > 0.4 IU/mL) and (2) demonstrate whether enoxaparin 0.5 mg/kg twice daily is not inferior to enoxaparin 40 mg twice daily for the pharmacokinetic endpoint of underanticoagulation (anti-Factor Xa < 0.2 IU/mL). The results of this trial will provide Level I evidence to help guide plastic surgeon’s choice of postoperative prophylactic anticoagulation.Keywords
This publication has 54 references indexed in Scilit:
- How Safe Is Thromboprophylaxis in Abdominoplasty?Plastic and Reconstructive Surgery, 2012
- Prevention of VTE in Nonorthopedic Surgical PatientsChest, 2012
- Parenteral AnticoagulantsChest, 2012
- Changing PracticePlastic and Reconstructive Surgery, 2011
- Validation of the Caprini Risk Assessment Model in Plastic and Reconstructive Surgery PatientsJournal of the American College of Surgeons, 2011
- Standard Prophylactic Enoxaparin Dosing Leads to Inadequate Anti-Xa Levels and Increased Deep Venous Thrombosis Rates in Critically Ill Trauma and Surgical PatientsJournal of Trauma: Injury, Infection & Critical Care, 2010
- Call to action to prevent venous thromboembolismJournal of Vascular Surgery, 2009
- The Epidemiology of Venous Thromboembolism in the CommunityArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- Current practice of thromboprophylaxis in the burn population: A survey study of 84 US burn centersBurns, 2005